These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23065664)

  • 1. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
    Whitson JT; Petroll WM
    Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells.
    Kahook MY; Ammar DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):259-63. PubMed ID: 20565312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
    Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
    Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
    Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.
    Yee RW; Norcom EG; Zhao XC
    Adv Ther; 2006; 23(4):511-9. PubMed ID: 17050493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
    Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
    Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
    Hedengran A; Freiberg J; May Hansen P; Boix-Lemonche G; Utheim TP; Dartt DA; Petrovski G; Heegaard S; Kolko M
    J Optom; 2024; 17(1):100481. PubMed ID: 37788596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
    Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
    Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
    Ammar DA; Kahook MY
    Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
    Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
    Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
    Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
    Baudouin C; Riancho L; Warnet JM; Brignole F
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
    Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells.
    Paimela T; Ryhänen T; Kauppinen A; Marttila L; Salminen A; Kaarniranta K
    Mol Vis; 2012; 18():1189-96. PubMed ID: 22605930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
    Ammar DA; Kahook MY
    Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
    Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.